AltMountain

Drug Royalties Fund II LLC

New York, NY · CIK 1723439
Status: no Form D since Dec 2017. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Drug Royalties Fund II LLC is a private equity fund based in New York, New York. Its most recent Form D, filed Dec 7, 2017, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Ross Stevens; James Rothwell; Patrick Kelly.

Total raised
$0Cumulative sales reported on Form D
Investors
0
First sale
—
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Ross Stevens; James Rothwell; Patrick Kelly
Latest Form D
Dec 7, 2017

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠

Related vehicles with the same name (3)

VehicleTotal raisedInvestorsLatest Form D
Drug Royalties Offshore Fund II LLC$00Dec 7, 2017
Drug Royalties Fund II LLC (this page)$00Dec 7, 2017
Drug Royalties Cayman Fund II LP$00Dec 7, 2017

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 3 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.

Questions about Drug Royalties Fund II LLC

What is the minimum investment for Drug Royalties Fund II LLC?

Drug Royalties Fund II LLC's latest Form D, filed Dec 7, 2017, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Drug Royalties Fund II LLC?

Drug Royalties Fund II LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Drug Royalties Fund II LLC raised?

Drug Royalties Fund II LLC's latest Form D, filed Dec 7, 2017, reports no sales yet.

Where is Drug Royalties Fund II LLC based?

Drug Royalties Fund II LLC is based in New York, New York.

Size compared with every private equity fund

This fund hasn't reported any sales yet.

More private equity funds in New York

Recently filed private equity funds in New York

All private equity funds in New York